您的位置: 首页 > 2023年8月 第54卷 第8期 > 文字全文
2023年7月 第38卷 第7期11
目录

融合基因分析方法在肿瘤研究中的应用与发展

Development and application of fusion gene analysis methods in tumors research

来源期刊: 广州医药 | 1-8 发布时间:2023-09-13 收稿时间:2025/11/13 18:31:29 阅读量:41
作者:
关键词:
融合基因分析工具检测验证
fusion geneanalysis toolsdetectionidentification
DOI:
10.3969/j.issn.1000-8535.2023.08.001
收稿时间:
2023-05-02 
修订日期:
 
接收日期:
 
引用总数:
1  
融合基因是指两个独立基因的编码区首尾相连所形成的且置于同一套调控序列控制的产物,研究表明许多癌症的发生与融合基因存在密切的联系。融合基因可作为癌症治疗的靶点,在癌症诊断及治疗领域中融合基因的研究具有重要意义。部分融合基因驱动癌症的机制已被初步揭示,但是有些真实存在的在肿瘤发生发展过程中有重要意义的融合基因由于工具和实验技术限制还未被发现。因此,对融合基因的分析预测研究方法逐渐成为关注的热点之一。本文探讨了目前常用的关于融合基因的分析工具及方法,为融合基因在癌症中的研究提供思路。
Fusion genes are the products of two independent genes whose coding regions are linked and controlled by the same set of regulatory sequences.Studies have shown that many cancers are closely linked to gene fusions.Fusion genes can be used as targets for cancer therapy,and the study of fusion genes is of great importance in cancer diagnosis and treatment.Some of the mechanisms of fusion genes driving cancer have been initially revealed,but there are more fusion genes which are important in the process of tumor development have not been discovered due to the limitation of tools and experimental techniques.Therefore,the analysis and prediction methods of fusion genes are becoming a hot topic of interest.In this paper,we discuss the commonly used analytical tools and methods on fusion genes to provide ideas for the study of fusion genes in cancer.
1、 XING Z,CHU C,CHEN L,et al.The use of Gene Ontology terms and KEGG pathways for analysis and prediction of oncogenes.[J].Biochim Biophys Acta,2016,1860(11 Pt B):2725-2734. XING Z,CHU C,CHEN L,et al.The use of Gene Ontology terms and KEGG pathways for analysis and prediction of oncogenes.[J].Biochim Biophys Acta,2016,1860(11 Pt B):2725-2734.
2、 张宁芮. 基于异构网络的疾病基因识别方法研究[D].乌鲁木齐:新疆大学,2021. 张宁芮. 基于异构网络的疾病基因识别方法研究[D].乌鲁木齐:新疆大学,2021.
3、 赵静,林丽梅.基于分子网络的疾病基因预测方法综述[J].电子科技大学学报,2017,46(5):755-765. 赵静,林丽梅.基于分子网络的疾病基因预测方法综述[J].电子科技大学学报,2017,46(5):755-765.
4、 王玉鹏. 基因选择性剪接位点鉴定与预测方法研究[D].南京:南京林业大学,2021. 王玉鹏. 基因选择性剪接位点鉴定与预测方法研究[D].南京:南京林业大学,2021.
5、 XU B,AL RASHEED M R H,ANTONESCU C R,et al.Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6-NTRK3 fusion[J].Histopathology,2020,76(3):375-382. XU B,AL RASHEED M R H,ANTONESCU C R,et al.Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6-NTRK3 fusion[J].Histopathology,2020,76(3):375-382.
6、 VAN BOCKSTAL M R,BENIUGA G,CRACIUN L,et al.The use of pan-tropomyosin receptor kinase immunohistochemistry as a screening tool for the detection of neurotrophic tropomyosin-related kinase fusions:Real-World Data from a national multicentric retrospective study[J].Pathobiology,2022,89(6):393-406. VAN BOCKSTAL M R,BENIUGA G,CRACIUN L,et al.The use of pan-tropomyosin receptor kinase immunohistochemistry as a screening tool for the detection of neurotrophic tropomyosin-related kinase fusions:Real-World Data from a national multicentric retrospective study[J].Pathobiology,2022,89(6):393-406.
7、 梁小芹,王玲,刘凤磊,等.免疫组织化学和荧光原位杂交检测肺腺癌ROS1表达的对比[J].临床与实验病理学杂志,2016,32(8):882-886. 梁小芹,王玲,刘凤磊,等.免疫组织化学和荧光原位杂交检测肺腺癌ROS1表达的对比[J].临床与实验病理学杂志,2016,32(8):882-886.
8、 LYU X,WANG X,ZHANG L,et al.Detection of 22 common leukemic fusion genes using a single-step multiplex qRT-PCR-based assay[J].Diagn Pathol,2017,12(1):55. LYU X,WANG X,ZHANG L,et al.Detection of 22 common leukemic fusion genes using a single-step multiplex qRT-PCR-based assay[J].Diagn Pathol,2017,12(1):55.
9、 FILIPOWICZ W,BHATTACHARYYA S N,SONENBERG N.Mechanisms of post-transcriptional regulation by microRNAs:are the answers in sight?[J].Nat Rev Genet,2008,9(2):102-114. FILIPOWICZ W,BHATTACHARYYA S N,SONENBERG N.Mechanisms of post-transcriptional regulation by microRNAs:are the answers in sight?[J].Nat Rev Genet,2008,9(2):102-114.
10、 LOVINO M,MONTEMURRO M,BARRESE V S,et al.Identifying the oncogenic potential of gene fusions exploiting miRNAs.[J].J Biomed Inform,2022(129):104057. LOVINO M,MONTEMURRO M,BARRESE V S,et al.Identifying the oncogenic potential of gene fusions exploiting miRNAs.[J].J Biomed Inform,2022(129):104057.
11、 KIM P,TAN H,LIU J,et al.FusionAI,a DNA-sequence-based deep learning protocol reduces the false positives of human fusion gene prediction[J].STAR Protoc,2022,3(1):101185. KIM P,TAN H,LIU J,et al.FusionAI,a DNA-sequence-based deep learning protocol reduces the false positives of human fusion gene prediction[J].STAR Protoc,2022,3(1):101185.
12、 KIM P,TAN H,LIU J,et al.FusionAI:Predicting fusion breakpoint from DNA sequence with deep learning[J].iScience,2021,24(10):103164. KIM P,TAN H,LIU J,et al.FusionAI:Predicting fusion breakpoint from DNA sequence with deep learning[J].iScience,2021,24(10):103164.
13、 WEBER D,IBN-SALEM J,SORN P,et al.Accurate detection of tumor-specific gene fusions reveals strongly immunogenic personal neo-antigens[J].Nature Biotechnol,2022,40(8):1276-1284. WEBER D,IBN-SALEM J,SORN P,et al.Accurate detection of tumor-specific gene fusions reveals strongly immunogenic personal neo-antigens[J].Nature Biotechnol,2022,40(8):1276-1284.
14、 KIM C,NA K,PARK S,et al.FusionPro,a versatile proteogenomic tool for identification of novel fusion transcripts and their potential translation products in cancer cells[J].Mol Cell Proteomics,2019,18(8):1651-1668. KIM C,NA K,PARK S,et al.FusionPro,a versatile proteogenomic tool for identification of novel fusion transcripts and their potential translation products in cancer cells[J].Mol Cell Proteomics,2019,18(8):1651-1668.
15、 CAI Z,XUE H,XU Y,et al.Fcirc:A comprehensive pipeline for the exploration of fusion linear and circular RNAs[J].Gigascience,2020,9(6):giaa054. CAI Z,XUE H,XU Y,et al.Fcirc:A comprehensive pipeline for the exploration of fusion linear and circular RNAs[J].Gigascience,2020,9(6):giaa054.
16、 KERBS P,VOSBERG S,KREBS S,et al.Fusion gene detection by RNA-sequencing complements diagnostics of acute myeloid leukemia and identifies recurring NRIP1-MIR99AHG rearrangements[J].Haematologica,2022,107(1):100-111. KERBS P,VOSBERG S,KREBS S,et al.Fusion gene detection by RNA-sequencing complements diagnostics of acute myeloid leukemia and identifies recurring NRIP1-MIR99AHG rearrangements[J].Haematologica,2022,107(1):100-111.
17、 STICHEL D,SCHRIMPF D,CASALINI B,et al.Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusions[J].Acta Neuropathol,2019,138(5):827-835. STICHEL D,SCHRIMPF D,CASALINI B,et al.Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusions[J].Acta Neuropathol,2019,138(5):827-835.
18、 UHRIG S,ELLERMANN J,WALTHER T,et al.Accurate and efficient detection of gene fusions from RNA sequencing data[J].Genome Res,2021,31(3):448-460. UHRIG S,ELLERMANN J,WALTHER T,et al.Accurate and efficient detection of gene fusions from RNA sequencing data[J].Genome Res,2021,31(3):448-460.
19、 LAHAYE S,VOYTOVICH K,FITCH J,et al.Utilization of an ensemble approach for identification of driver fusions in pediatric cancer[C].Proceedings:AACR Annual Meeting 2019,2019. LAHAYE S,VOYTOVICH K,FITCH J,et al.Utilization of an ensemble approach for identification of driver fusions in pediatric cancer[C].Proceedings:AACR Annual Meeting 2019,2019.
20、 DAVIDSON N M,MAJEWSKI I J,OSHLACK A.JAFFA:High sensitivity transcriptome-focused fusion gene detection[J].Genome Med,2015,7(1):43. DAVIDSON N M,MAJEWSKI I J,OSHLACK A.JAFFA:High sensitivity transcriptome-focused fusion gene detection[J].Genome Med,2015,7(1):43.
21、 HAAS B J,DOBIN A,LI B,et al.Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods[J].Genome Biol,2019,20(1):213. HAAS B J,DOBIN A,LI B,et al.Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods[J].Genome Biol,2019,20(1):213.
22、 HAAS B J,DOBIN A,STRANSKY N,et al.STAR-Fusion:Fast and Accurate Fusion Transcript Detection from RNA-Seq[DB].bioRxiv,2017:120295.http://repositary.cshl.edu/id/eprint/40278 HAAS B J,DOBIN A,STRANSKY N,et al.STAR-Fusion:Fast and Accurate Fusion Transcript Detection from RNA-Seq[DB].bioRxiv,2017:120295.http://repositary.cshl.edu/id/eprint/40278
23、 OKONECHNIKOV K,IMAI-MATSUSHIMA A,PAUL L,et al.InFusion:Advancing discovery of fusion genes and chimeric transcripts from deep RNA-sequencing data[J].PLOS ONE,2016,11(12):e167417. OKONECHNIKOV K,IMAI-MATSUSHIMA A,PAUL L,et al.InFusion:Advancing discovery of fusion genes and chimeric transcripts from deep RNA-sequencing data[J].PLOS ONE,2016,11(12):e167417.
24、 LIU S,TSAI W,DING Y,et al.Comprehensive evaluation of fusion transcript detection algorithms and a meta-caller to combine top performing methods in paired-end RNA-seq data[J].Nucleic Acids Res,2016,44(5):e47. LIU S,TSAI W,DING Y,et al.Comprehensive evaluation of fusion transcript detection algorithms and a meta-caller to combine top performing methods in paired-end RNA-seq data[J].Nucleic Acids Res,2016,44(5):e47.
25、 LIU Z,CHEN X,ROBERTS R,et al.Unraveling gene fusions for drug repositioning in high-risk neuroblastoma[J].Front Pharmacol,2021(12):608778. LIU Z,CHEN X,ROBERTS R,et al.Unraveling gene fusions for drug repositioning in high-risk neuroblastoma[J].Front Pharmacol,2021(12):608778.
26、 VU T N,DENG W,TRAC Q T,et al.A fast detection of fusion genes from paired-end RNA-seq data[J].BMC Genomics,2018,19(1):786. VU T N,DENG W,TRAC Q T,et al.A fast detection of fusion genes from paired-end RNA-seq data[J].BMC Genomics,2018,19(1):786.
27、 JIA W,QIU K,HE M,et al.SOAPfuse:an algorithm for identifying fusion transcripts from paired-end RNA-Seq data[J].Genome Biol,2013,14(2):R12. JIA W,QIU K,HE M,et al.SOAPfuse:an algorithm for identifying fusion transcripts from paired-end RNA-Seq data[J].Genome Biol,2013,14(2):R12.
28、 MAHER C A,KUMAR-SINHA C,CAO X,et al.Transcriptome sequencing to detect gene fusions in cancer[J].Nature,2009,458(7234):97-101. MAHER C A,KUMAR-SINHA C,CAO X,et al.Transcriptome sequencing to detect gene fusions in cancer[J].Nature,2009,458(7234):97-101.
29、 FRENKEL-MORGENSTERN M.Identification of chimeric rnas using RNA-Seq reads and protein-protein interactions of translated chimeras[J].Methods Mol Biol,2020(2079):27-40. FRENKEL-MORGENSTERN M.Identification of chimeric rnas using RNA-Seq reads and protein-protein interactions of translated chimeras[J].Methods Mol Biol,2020(2079):27-40.
30、 GUARNERIO J,BEZZI M,JEONG J C,et al.Oncogenic role of fusion-circRNAs derived from cancer-associated chromosomal translocations[J].Cell,2016,165(2):289-302. GUARNERIO J,BEZZI M,JEONG J C,et al.Oncogenic role of fusion-circRNAs derived from cancer-associated chromosomal translocations[J].Cell,2016,165(2):289-302.
31、 WU K,LIAO X,GONG Y,et al.Circular RNA F-circSR derived from SLC34A2-ROS1 fusion gene promotes cell migration in non-small cell lung cancer[J].Mol Cancer,2019,18(1):98. WU K,LIAO X,GONG Y,et al.Circular RNA F-circSR derived from SLC34A2-ROS1 fusion gene promotes cell migration in non-small cell lung cancer[J].Mol Cancer,2019,18(1):98.
32、 BABIN L,ANDRAOS E,FUCHS S,et al.From circRNAs to fusion circRNAs in hematological malignancies[J].JCI Insight,2021,6(21):e151513. BABIN L,ANDRAOS E,FUCHS S,et al.From circRNAs to fusion circRNAs in hematological malignancies[J].JCI Insight,2021,6(21):e151513.
33、 KATAYAMA R,LOVLY C M,SHAW A T.Therapeutic targeting of anaplastic lymphoma kinase in lung cancer:a paradigm for precision cancer medicine[J].Clin Cancer Res,2015,21(10):2227-2235. KATAYAMA R,LOVLY C M,SHAW A T.Therapeutic targeting of anaplastic lymphoma kinase in lung cancer:a paradigm for precision cancer medicine[J].Clin Cancer Res,2015,21(10):2227-2235.
34、 SARFATY M,MOORE A,NEIMAN V,et al.RET fusion lung carcinoma:Response to therapy and clinical features in a case series of 14 Patients[J].Clin lung Cancer,2017,18(4):e223-e232. SARFATY M,MOORE A,NEIMAN V,et al.RET fusion lung carcinoma:Response to therapy and clinical features in a case series of 14 Patients[J].Clin lung Cancer,2017,18(4):e223-e232.
35、 HEISTERKAMP N,STAM K,GROFFEN J,et al.Structural organization of the bcr gene and its role in the Ph’ translocation[J].Nature,1985,315(6022):758-761. HEISTERKAMP N,STAM K,GROFFEN J,et al.Structural organization of the bcr gene and its role in the Ph’ translocation[J].Nature,1985,315(6022):758-761.
36、 GUPTA S K,JEA J D,YEN L.Validating gene fusion as the source of chimeric RNAs[J].Methods in Mol Biol,2020(2079):187-207. GUPTA S K,JEA J D,YEN L.Validating gene fusion as the source of chimeric RNAs[J].Methods in Mol Biol,2020(2079):187-207.
37、 BRUNO R,FONTANINI G.Next generation sequencing for gene fusion analysis in lung cancer:a literature review[J].Diagnostics(Basel,Switzerland),2020,10(8):521. BRUNO R,FONTANINI G.Next generation sequencing for gene fusion analysis in lung cancer:a literature review[J].Diagnostics(Basel,Switzerland),2020,10(8):521.
38、 WANG J,DEAN D C,HORNICEK F J,et al.RNA sequencing(RNA-Seq)and its application in ovarian cancer[J].Gynecol Oncol,2019,152(1):194-201. WANG J,DEAN D C,HORNICEK F J,et al.RNA sequencing(RNA-Seq)and its application in ovarian cancer[J].Gynecol Oncol,2019,152(1):194-201.
39、 GABERT J,BEILLARD E,van der VELDEN V H J,et al.Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program[J].Leukemia,2003,17(12):2318-2357. GABERT J,BEILLARD E,van der VELDEN V H J,et al.Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program[J].Leukemia,2003,17(12):2318-2357.
40、 JIANG T,WANG G,LIU Y,et al.Development of small-molecule tropomyosin receptor kinase(TRK)inhibitors for NTRK fusion cancers[J].Acta Pharm Sin B,2021,11(2):355-372. JIANG T,WANG G,LIU Y,et al.Development of small-molecule tropomyosin receptor kinase(TRK)inhibitors for NTRK fusion cancers[J].Acta Pharm Sin B,2021,11(2):355-372.
41、 DE BRAEKELEER E,DOUET-GUILBERT N,DE BRAEKELEER M.RARA fusion genes in acute promyelocytic leukemia:a review[J].Expert Rev Hematol,2014,7(3):347-357. DE BRAEKELEER E,DOUET-GUILBERT N,DE BRAEKELEER M.RARA fusion genes in acute promyelocytic leukemia:a review[J].Expert Rev Hematol,2014,7(3):347-357.
42、 GARCíA-PERDOMO H A,CHAVES M J,OSORIO J C,et al.Association between TMPRSS2:ERG fusion gene and the prostate cancer:systematic review and meta-analysis[J].Cent European J Urol,2018,71(4):410-419. GARCíA-PERDOMO H A,CHAVES M J,OSORIO J C,et al.Association between TMPRSS2:ERG fusion gene and the prostate cancer:systematic review and meta-analysis[J].Cent European J Urol,2018,71(4):410-419.
43、 SALVATORE D,SANTORO M,SCHLUMBERGER M.The importance of the RET gene in thyroid cancer and therapeutic implications[J].Nature reviews Endocrinology,2021,17(5):296-306. SALVATORE D,SANTORO M,SCHLUMBERGER M.The importance of the RET gene in thyroid cancer and therapeutic implications[J].Nature reviews Endocrinology,2021,17(5):296-306.
44、 TOGNON C,KNEZEVICH S R,HUNTSMAN D,et al.Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma[J].Cancer cell,2002,2(5):367-376. TOGNON C,KNEZEVICH S R,HUNTSMAN D,et al.Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma[J].Cancer cell,2002,2(5):367-376.
45、 CHAPMAN A M,SUN K Y,RUESTOW P,et al.Lung cancer mutation profile of EGFR,ALK,and KRAS:Meta-analysis and comparison of never and ever smokers[J].Lung Cancer,2016(102),122-134. CHAPMAN A M,SUN K Y,RUESTOW P,et al.Lung cancer mutation profile of EGFR,ALK,and KRAS:Meta-analysis and comparison of never and ever smokers[J].Lung Cancer,2016(102),122-134.
46、 OSMAN A E G,DEININGER M W.Chronic Myeloid Leukemia:Modern therapies,current challenges and future directions[J].Blood Rev,2021,49:100825. OSMAN A E G,DEININGER M W.Chronic Myeloid Leukemia:Modern therapies,current challenges and future directions[J].Blood Rev,2021,49:100825.
47、 ROWLEY J D.Letter:A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining[J].Nature,1973,243(5405):290-293. ROWLEY J D.Letter:A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining[J].Nature,1973,243(5405):290-293.
48、 MITELMAN F,JOHANSSON B,MERTENS F.The impact of translocations and gene fusions on cancer causation[J].Nature reviews.Cancer,2007,7(4):233-245. MITELMAN F,JOHANSSON B,MERTENS F.The impact of translocations and gene fusions on cancer causation[J].Nature reviews.Cancer,2007,7(4):233-245.
1、张志远,郑直,田晓怡.融合基因检测方法的最新研究进展[J].现代检验医学杂志,2024,39(05):205-212. 张志远,郑直,田晓怡.融合基因检测方法的最新研究进展[J].现代检验医学杂志,2024,39(05):205-212.
下一篇
出版者信息








《广州医药》公众号
目录